missing translation for 'onlineSavingsMsg'
Få mere at vide

Pamufetinib mesylate, MedChemExpress

Artikelnummer. 16491377
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
50 mg
100 mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
16491377 50 mg
16467877 5 mg
16425158 10 mg
16415866 100 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 16491377 Leverandør Medchem Express Leverandørnr. HY12423A

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Pamufetinib (TAS-115) mesylate is a potent VEGFRand hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor, with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.

Pamufetinib (TAS-115) mesylate is a potent VEGFRand hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor, with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.

Specifications

Kemisk navn eller materiale Pamufetinib mesylate
CAS 1688673-09-7
Farve White
Renhedsgrad noter Research
Molekylær formel C28H27FN4O7S2
Mængde 50 mg
Synonym TAS-115 mesylate
Opløselighedsinformation DMSO : 75 mg/mL (122.02 mM; Need ultrasonic)
SMIL CS(=O)(O)=O.O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC(CC4=CC=CC=C4)=O)=S)C=C3F)C2=C1)NC
Molekylvægt (g/mol) 614.66
Formel vægt 614.66
Procent renhed 99.19%
Grad Research
Fysisk form Solid
Til brug med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.